Company receives grant from Innovate UK Smart Grant London, 20 July 2020 – Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to treat cancer, today announced the award of a £0.5 million grant from the...
July 20, 2020 - Press Releases